Physician profile
Stacey E Brown
NPI 1861931461
$1,321.93
in general payments reported to CMS, 2019-2025
13 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $718 · 2023: $130 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $300.27 | 2022-2025 | Airsupra, Fasenra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $194.59 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $124.80 | 2025 | Zoryve |
| Biohaven Pharmaceutical Holding Company Ltd. | $124.75 | 2022 | |
| Novo Nordisk INC | $124.49 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $111.78 | 2022 | |
| Scynexis, INC. | $105.20 | 2022 | |
| Csl Behring | $101.84 | 2022-2023 | Haegarda, Kcentra |
| Abbvie INC. | $50.00 | 2021 | |
| Neurelis, INC. | $34.05 | 2023 | Valtoco |
| Inspire Medical Systems, INC. | $19.56 | 2025 | Inspire |
| Pharming Healthcare, INC. | $15.65 | 2023 | Ruconest |
| Laborie Medical Technologies Corp. | $14.95 | 2025 | Eclipse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.